|
Navigation
Recherche
|
AstraZeneca bets $247M AI can create a cancer-fighting antibody
lundi 4 décembre 2023, 23:35 , par TheRegister
Startup Absci will turn to its generative AI algorithms to design synthetic protein
Pharma giant AstraZeneca has signed a $247 million deal with Ai drug creation company Absci to develop an antibody designed to fight cancer.…
https://go.theregister.com/feed/www.theregister.com/2023/12/04/astrazeneca_absci_cancer/
|
56 sources (32 en français)
Date Actuelle
sam. 10 mai - 13:37 CEST
|
Lire la suite sur TheRegister